AKT1 and ovarian cancer: Third, T-type Ca2+ channels, which are aberrantly overexpressed in ovarian cancer, can activate the PI3K/AKT pathway, thus antagonizing FOXO3A nuclear retention and promoting FOXM1 expression [153].